Scientific Rationale for Using High-Dose Multiple Micronutrients as an Adjunct to Standard and Experimental Cancer Therapies

Journal of the American College of Nutrition

Volumn 20, Issue , 2001, Pages 450S-463S

  Prasad, Kedar N ^a   Cole, William C ^a   Kumar, Bipin ^a   Prasad, K Che ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; CAMP; Cancer therapy; Hyperthermia; Sodium butyrate

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; TRACE ELEMENT;

CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; HYPERTHERMIC THERAPY; IMMUNOTHERAPY; NUTRIENT; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; HUMANS; MICRONUTRIENTS; NEOPLASMS; TREATMENT OUTCOME;

EID: 0034790946     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2001.10719184     Document Type: Article

References (78)

1. Prasad KN, Kumar A, Kochupillai MD, Cole WC: High doses of multiple antioxidant vitamins: Essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 18: 13-25, 1999.
2. Prasad KN, Cole WC, Hovland P: Cancer prevention studies: Past, present and future. Nutrition 14: 197-210, 1998.
3. Cole WC, Prasad KN: Contrasting effects of vitamins as modulators of apoptosis in cancer cells and normal cells: A review. Nutr Cancer 29: 97-103, 1997.
4. Labriola D, Livingston R: Possible interactions between dietary antioxidants and chemotherapy. Oncology 13: 1003-1008, 1999.
5. Prasad KN, Edwards-Prasad J: Expressions of some molecular cancer risk factors and their modification by vitamins. J Am Coll Nutr 9: 28-34, 1990.
6. Schwartz JL: Molecular and biochemical control of tumor growth following treatment with carotenoids or tocopherols. In Prasad KN, Santamaria L, Williams RM (eds): “Nutrients in Cancer Prevention and Treatment.” New Jersey: Humana Press, 287-316, 1995.
7. Amatruda TTD, Sidell N, Ranyard J, Koeffler HP: Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression. Biochem Biophys Res Commun 126: 1189-95, 1985.
8. Gopalakrishna R, Gundimeda U, Chen Z: Vitamin E succinate inhibits protein kinase C: Correlation with its unique inhibitory effects on cell growth and transformation. In Prasad K, Santamaria L, Williams R (eds): “Nutrients in Cancer Prevention and Treatment.” Totowa, New Jersey: Human Press, 21-37, 1995.
9. Mahoney C, Azzi A: Vitamin E inhibits protein kinase C activity. Biochem Biophys Res Commun 154: 694-697, 1988.
10. Kline K, Yu W, Zhao B: Vitamin E succinate: Mechanisms of action as tumor cell growth inhibitor. In Prasad K, Santamaria L, Williams R (eds): “Nutrients in Cancer Prevention and Treatment.” New Jersey: Humana Press, 39-55, 1995.
11. Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp D, Coffey RJ: Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAFI/CIPI via C/EBPb. Nature Med 3: 1233-1241, 1997.
12. Turley JM, Fu T, Ruscetti FW, Mikovits JA, Bertolette DC, III, Birchenall-Roberts MC: Vitamin E succinate induces Fasmediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res 57: 881-90, 1997.
13. Yu W, Israel K, Liao QY, Aldaz CM, Sanders BG, Kline K: Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res 59: 953-61, 1999.
14. Turley J, Ruscetti F, Kim S-J, Fu T: Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: Increased binding of cyclic AMP negatively regulates E2F transactivation activity. Cancer Res 57: 2668-2675, 1997.
15. Zhang LX, Cooney RV, Bertram JS: Carotenoids up-regulate connexin-43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res 52: 5707-5712, 1992.
16. Prasad KN, Kumar R: Effect of individual antioxidant vitamins alone and in combination on growth and differentiation of human non-tumorigenic and tumorigenic parotid acinar cells in culture. Nutr Cancer 26: 11-19, 1996.
17. Park CH: Vitamin C in leukemia and preleukemia cell growth. Prog Clin Biol Res 259: 321-330, 1988.
18. Cohen M, Bhagavan HN: Ascorbic Acid and Gastrointestinal Cancer. J Am Coll Nutr 14: 565-578, 1995.
19. Anonymous: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group [see comments]. N Engl J Med 330: 1029-35, 1994.
20. Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson WA: Modification of the effect of tamoxifen, cis-platin, DTIC and interferon-a2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer 22: 233-245, 1994.
21. Prasad KN, Cole W, Prasad JE: Multiple antioxidant vitamins as an adjunct to standard and experimental therapies. Z Onkol/J Oncol 31: 4-11, 1999.
22. Israel K, Yu W, Sanders BG, Kline K: Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr Cancer 36: 90-100, 2000.
23. Jha MN, Bedford JS, Cole WC, Edwards-Prasad J, Prasad KN: Vitamin E (d-a tocopheryl succinate) decreases mitotic accumulation in -irradiated human tumor, but not in normal cells. Nutr Cancer 35: 189-194, 1999.
24. Kumar B, Jha MN, Cole WC, Bedford JS, Prasad KN: d-Alpha tocopheryl succinate (vitamin E) enhances radiation-induced chromosomal damage levels in human cancer cells, but reduces it in normal cells. J Am Coll Nutr, submitted, 2001.
25. Seifter E, Rettura A, Padawar J, Levenson SM: Vitamin A and -carotene as adjunctive therapy to tumor excision, radiation therapy and chemotherapy. In Prasad KN (ed): “Vitamins, Nutrition and Cancer.” Basel: Karger, 1-19, 1984.
26. Garewal H: Beta-carotene and antioxidant nutrients in oral cancer prevention. In Prasad KN, Santamaria L, Williams RM (eds): “Nutrients in Cancer Prevention and Treatment.” New Jersey: Human Press, 235-247, 1995.
27. Malafa MP, Neitzel LT: Vitamin E succinate promotes breast cancer dormancy and inhibits VEGF gene expression. Frontiers of Pharmacology and Therapeutics in 21st Century. New Delhi, India, pp 15-19, 1999.
28. Meyskens FL: Role of vitamin A and its derivatives in the treatment of human cancer. In Prasad KN, Santamaria L, Williams RM (eds): “Nutrients in Cancer Prevention and Treatment.” Totowa, New Jersey: Humana Press, 349-362, 1995.
29. Cameron E, Pauling L, Leibowitz B: Ascorbic acid and cancer. A review. Cancer Res 39: 663-681, 1979.
30. Dreno B: Roferon-A (interferon alpha 2a) combined with Tigason (etretinate) for treatment of cutaneous T cell lymphomas. Stem Cells 11: 269-275, 1993.
31. Lippman SM, Parkinson DR, Itri LM, et al: 13-cis retinoic acid plus interferon -2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84: 241-245, 1995.
32. Salganik R, Albright C, Rodgers J, et al: Enhancement of apoptosis and inhibbrain tumor growth in transgenic mice by depletion of antioxidants (abstract). American Society for Cell Biology, Annual Meeting, 1999. Wahington, D.C.: Am Soc Cell Biol, 444a, 1999.
33. Traber MG, Packer L: Vitamin E: beyond antioxidant function. American Journal of Clinical Nutrition 62: 1501S-1509S, 1995.
34. Krinsky N: Antioxidant Functions of Carotenoids. Free Radical Biol & Med 7: 617-635, 1989.
35. Vile GF, Winterbourn CC: Inhibition of Adriamycin Promoted Microsomal Lipid Peroxidation By -Carotene, -Tocopherol and Retinal At High and Low Oxygen Partial Pressure. FEBS Lett 238: 353-356, 1988.
36. McCay PB: Vitamin E: Interactions With Free Radicals and Ascorbate. Ann Rev Nutr 5: 323-340, 1985.
37. Carini R, Poli G, Dianzani MU, Maddix SP, Slater TF, Cheeseman KH: Comparative evaluation of the amount of the antioxidant activity of -tocopherol, -tocopherol polyethylene glycol 1000 succinate and -tocopherol succinate in isolated hepatocytes and liver microsomal suspensions. Biochem Pharmacol 39: 1597-1601, 1990.
38. Sporn MB, Roberts AB: Role of retinoids in differentiation and carcinogenesis. Cancer Res 43: 3034-3040, 1983.
39. Carter CA, Pogribny M, Davidson A, Jackson CD, McGarrity LJ, Morris SM: Effects of retinoic acid on cell differentiation and reversion towards normal in human endometrial adenocarcinoma (RL95-2) cells. Anticancer Res 16: 17-24, 1996.
40. Hazuka MB, Edwards-Prasad J, Newman F, Kinzie JJ, Prasad KN: Beta-carotene induces morphological differentiation and decreases adenylate cyclase activity in melanoma cells in culture. J Am Coll Nutr 9: 143-9, 1990.
41. Prasad KN, Edwards-Prasad J: Effect of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res 42: 550-555, 1982.
42. Prasad KN, Sinha PK, Ramanujam M, Sakamoto A: Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci USA 76: 829-832, 1979.
43. Formelli F, Cleris L: Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity. Cancer Res 53: 5374-6, 1993.
44. DeLaney TF, Afridi N, Taghian AG, et al.: 13-cis-retinoic acid with alpha-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro. Cancer Res 56: 2277-80, 1996.
45. Jaakkola K, Lahteenmaki P, Laakso J, Harju E, Tykka H, Mahlberg K: Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with smallcell lung cancer. Anticancer Res 12: 599-606, 1992.
46. Lamson DW, Brignall MS: Antioxidants in cancer therapy; Their actions and interactions with oncologic therapies. Alternative Med Rev 4: 304-329, 1999.
47. Mills EE: The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis. Brit J Cancer 57: 416-417, 1988.
48. Lippman SM, Kavanagh JJ, Parades M, Delgadillo F, Hong WK, Figuerda F, et al: 13-cis-retinoic acid (13-cRA), interferon 2a and radiotherapy for locally advanced cancer of cervix. Proc Am Soc Clin Oncol 12: 257, 1993.
49. Blumenthal RD, Lew W, Reising A, et al.: Anti-oxidant vitamins reduce normal tissue toxicity induced by radio-immunotherapy. Int J Cancer 86: 276-80, 2000.
50. Hanck AB: Vitamin C and cancer. Prog Clin Biol Res 259: 307-20, 1988.
51. Piyathilake CJ, Bell WC, Johanning GL, Cornwell PE, Heimburger DC, Grizzle WE: The accumulation of ascorbic acid by squamous cell carcinomas of the lung and larynx is associated with global methylation of DNA. Cancer 89: 171-6, 2000.
52. Rutz H, Little J: Modification of radiosensitivity and recovery from x-ray damage in vitro, by retinoic acid. Int J Rad Oncol Biol Physics 16: 1285-1288, 1981.
53. Sahu SN, Prasad KN: Combined effect of adenosine 3,5-cyclic monophosphate stimulating agents, vitamin E succinate, and heat on the survival of murine B-16 melanoma cells in culture. Cancer 62: 949-953, 1988.
54. Rama BN, Prasad KN: Effect of hyperthermia in combination with vitamin E and cyclic AMP on neuroblastoma cells in culture. Life Sci 34: 2089-2097, 1984.
55. Prasad KN, Kentroti S, Edwards-Prasad J, et al.: Modification of the expression of adenosine 3,5-cyclic monophosphate-induced differentiated functions in neuroblastoma cells by beta-carotene and D-alpha-tocopheryl succinate. J Am Coll Nutr 13: 298-303, 1994.
56. Prasad KC: Induction of differentiated phenotypes in melanoma cells by a combination of an adenosine 3,5-cyclic monophosphate stimulating agent and d--tocopheryl succinate. Cancer Lett 116: 17-22, 1989.
57. Rama BN, Prasad KN: Effect of dl-alpha-tocopheryl succinate in combination with sodium butyrate and cAMP-stimulating agents on neuroblastoma cells in culture. Int J Cancer 34: 863-867, 1984.
58. Yamanaka N, Fukishima M, Koizumi K, Nishida K, Kato T, et al: Enhancement of DNA chain breakage by bleomycin and biological free radical producing systems. In DeDuve C, Hayashi T (eds): “Tocopherol, Oxygen and Biomembranes.” New York: North Holland, 59-69, 1978.
59. Myers CE, McGuire W, Young R: Adriamycin: Amelioration of toxicity by alpha-tocopherol. Cancer Treatment Reports 60: 961-962, 1976.
60. Sonnevald P: Effect of alpha tocopherol on cardiotoxicity of adriamycin in the rat. Cancer Treat Rep 62: 1033-1036, 1978.
61. Van Vleet JF, Greenwood L, Ferands VJ, Rebar AH: Effect of selenium-vitamin E on adriamycin-induced cardiomyopathy in rabbits. Am J Vitamin Res 39: 997-1010, 1978.
62. Wang YM, Madanat FF, Kimball JC, Gieser CA, Ali MK, et al: Effect of vitamin E against adriamycin-induced toxicity in rabbits. Cancer Res 40: 1022-1027, 1980.
63. Svingen BA, Powis A, Abbel PL, Scott M: Protection against adriamycin-induced skin necrosis in the rat by dimethylsulfoxide and alpha-tocopherol. Cancer Res 41: 3395-3399, 1981.
64. Geetha A, Sankar R, Marar T, Devi CSS: Alpha tocopherol reduces doxorubicin-induced toxicity in rats-histological and biochemical evidences. Indian Physiol Pharmacol 34: 94-98, 1990.
65. Srinavasan V, Jacobs AL, Simpson SA, Weiss JF: Radioprotection by vitamin E. Effect on hepatic enzymes, delayed type hypersensitivity and post-irradiation survival in mice. In Meyskens FLJ, Prasad KN (eds): “Modulation and Mediations of Cancer Cells by Vitamins.” Basel: Karger, 119-131, 1983.
66. Malick MA, Roy RM, Sternberg J: Effect of vitamin E on postirradiation death in mice. Experientia 34: 1216-1217, 1978.
67. Londer HM, Myers CE: Radioprotective effects of vitamin E (abstract). Am J Clin Nutr 31: 705a, 1978.
68. Fujita K, Shinpo K, Sato T, Niime H, Shamoto M, et al: Reduction of adriamycin-toxicity by ascorbate in mice and guinea pigs. Cancer Res 42: 309-316, 1982.
69. Trizna Z, Schantz SP, Lee JJ, Spitz MR, Goepfert H, et al: In vitro protective effect of chemopreventive agents against bleomycininduced genotoxicity in lymphoblastoid cell lines and peripheral lymphocytes of head and neck cancer patients. Cancer Detect Prev 17: 575-583, 1993.
70. Delanian S: Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Br J Rad 71: 892-894, 1998.
71. Konopacka M, Widel M, Rzeszowska-Wolny J: Modifying effect of vitamins C, E and beta-carotene against gamma-ray-induced DNA damage in mouse cells. Mut Res 417: 85-94, 1998.
72. Babu JR, Sundravel S, Arumugam G, Renuka R, Deepa N, Sachdanandam P: Salubrious effects of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels. Cancer Lett 151: 1-5, 2000.
73. Creagan ET, Moertel CG, O’Fallon JR: Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. N Engl J Med 301: 687-690, 1979.
74. Fukushima S, Imaida K, Shibata M-K, Tamano S, Kurata Y, Shirai T: L-ascorbic acid amplification of second-stage bladder carcinogenesis promotion by NaHCO3. Cancer Res 48: 6317-6320, 1988.
75. Ingold KU, Burton GW, Foster DO, Hughes L, Lindsay DA, Webb A: Biokinetics of and discrimination between dietary RRR-and SRR-alpha-tocopherols in the male rat. Lipids 22: 163-172, 1987.
76. Kennedy AR, Krinsky NI: Effects of retinoids, -carotene and canthaxanthene on U.V. and x-ray-induced transformation of C3H10T 1/2 cells in vitro. Nutr Cancer 22: 219-232, 1994.
77. Prasad KN: “Handbook of Radiobiology,” 2nd ed. Boca Raton, Fl: CRC Press, 1995.
78. Sinclair WK: Cysteamine: differential x-ray protective effect on Chinese hamster cells during the cell cycle. Science 159: 442-4, 1968.